## EQR: Equity Residential - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 8.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($60.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Sarasin & Partners LLP Decreases Position in Equity Residential $EQR**
- Source: MarketBeat | 20251221T124706 | Neutral | Relevance: 100%
- Sarasin & Partners LLP significantly reduced its stake in Equity Residential (NYSE:EQR) by 65% in Q3, selling 60,094 shares and retaining 32,408 shares valued at approximately $2.08 million. Despite this reduction, Equity Residential reported Q3 EPS in line with estimates, provided optimistic Q4 and FY2025 guidance, and declared a quarterly dividend of $0.6925. The company's stock shows a market cap of $23.39 billion with a dividend yield of 4.5%, and institutional investors collectively own 92.68% of its shares.

**2. U.S. Capital Wealth Advisors LLC Has $8.64 Million Stake in Equity Residential $EQR**
- Source: MarketBeat | 20251220T140745 | Somewhat-Bullish | Relevance: 100%
- U.S. Capital Wealth Advisors LLC significantly increased its stake in Equity Residential (NYSE:EQR) during Q3, now holding 133,547 shares valued at $8.64 million. Equity Residential announced a quarterly dividend of $0.6925, resulting in a 4.5% yield and reported Q3 EPS of $1.02, meeting estimates, with a FY2025 guidance of $3.98â€“$4.02 EPS. The stock currently carries an average "Hold" rating from analysts with a consensus price target of $70.02.

**3. Equity Residential $EQR Shares Purchased by Thrivent Financial for Lutherans**
- Source: MarketBeat | 20251220T110810 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Equity Residential (NYSE: EQR) by 69.5% in the second quarter, now owning 81,196 shares valued at approximately $5.48 million. Other institutional investors also modified their holdings, with overall institutional ownership standing at about 92.68%. Equity Residential reported Q2 earnings of $1.02 EPS, matching estimates, and revenue of $782.41 million, while announcing a quarterly dividend of $0.6925 per share.

**4. How Investors May Respond To Regency Centers (REG) Adding Equity Residential CEO Mark Parrell To Its Board**
- Source: Simply Wall Street | 20251221T234032 | Neutral | Relevance: 63%
- Regency Centers (REG) has appointed Mark J. Parrell, CEO of Equity Residential, to its Board of Directors, expanding it to twelve members and giving him roles on the Audit and Investment committees. This move is seen as an incremental governance positive, bringing expertise in real estate and capital allocation, but it doesn't fundamentally alter the investment narrative or risks associated with development-heavy growth. Investors should watch how Regency balances its recent dividend increase with its substantial development pipeline, especially concerning potential rising costs or tighter capital markets.

**5. Camden Property Trust (CPT): Reassessing Valuation After Dual Listing, 2025 Guidance Upgrade and JP Morgan Rating Boost**
- Source: Simply Wall Street | 20251221T182947 | Neutral | Relevance: 61%
- Camden Property Trust (CPT) experienced three recent positive catalysts: a new NYSE Texas dual listing, upgraded 2025 guidance, and a JP Morgan rating increase, influencing investor perception. Despite a negative year-to-date share price return, its five-year total shareholder return indicates long-term momentum. The stock is considered 8.1% undervalued with a fair value of $116.67, driven by operating efficiency and capital management, though valuation models show it trading higher than peers based on its P/E ratio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Barclays | $77 | $80 | -4% |
| 2025-11-24 | Mizuho | $65 | $66 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Barclays | main | Overweight |
| 2025-11-24 | Mizuho | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.1% (+2.3%)
- Blackrock Inc.: 10.2% (+1.1%)
- State Street Corpora: 6.6% (+2.8%)
- Price (T.Rowe) Assoc: 5.2% (-4.5%)
- Apg Asset Management: 3.0% (-0.7%)

### Key Risks

1. Valuation stretched: PEG 8.2x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 8.15 signals overvaluation risk, limited margin of safety. Forward P/E 43.5x stretched relative to 6% growth. Quality metrics strong (margin 38%). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.5B |
| Beta | 0.76 |
| 52W Range | $58.38 - $75.86 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.15 |
| Forward P/E | 43.5 |
| Current P/E | 46.2 |
| YoY Growth | 6.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.1% (minimal 5-day change). Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_10 - short-term weakness emerging. Outperforming sector by 3.3pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. RSI neutral at 59. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.06% (CS: 71) | Neutral |
| RSI_14 | 58.8 | Neutral |
| MACD Histogram | 0.14 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 0.950x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $62.29
- **Stop Loss:** $60.21 (3.3% risk)
- **Target:** $64.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 288
- **Position Value:** $17,939.52
- **Portfolio %:** 17.94%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-09 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.37 | -11.5% |
| 2025Q2 | $0.30 | $0.34 | +12.6% |
| 2025Q1 | $0.27 | $0.26 | -4.9% |
| 2024Q4 | $0.40 | $0.26 | -35.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*